Literature DB >> 21059588

Oncology nurses' use of National Comprehensive Cancer Network clinical practice guidelines for chemotherapy-induced and febrile neutropenia.

Anita Nirenberg1, Nancy K Reame, Kenrick D Cato, Elaine L Larson.   

Abstract

PURPOSE/
OBJECTIVES: To describe oncology nurses' use of National Comprehensive Cancer Network (NCCN) clinical practice guidelines for chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN).
DESIGN: Cross-sectional survey design; descriptive, correlational analysis.
SETTING: E-mail invitation to Web-based survey. SAMPLE: Random sample of 309 Oncology Nursing Society (ONS) members with e-mail addresses who provide care to adult patients receiving chemotherapy.
METHODS: The investigator-developed Neutropenia Oncology Nurses Survey was used. Descriptive tests compared respondents' personal and professional characteristics to those of general ONS members; nonparametric chi-square and Kruskal-Wallis tests were used to correlate respondents' survey subscale scores with demographic data. Significant associations were entered into multiple logistic regression models. MAIN RESEARCH VARIABLES: The Neutropenia Oncology Nurses Survey's subscales measured subjective norm, attitude, perceived competence and confidence, perceived barriers, and use of NCCN clinical practice guidelines for CIN and FN.
FINDINGS: Response rate of nurses who opened the survey was 50%. Most practiced in community versus academic centers. Eighty percent reported using the NCCN clinical practice guidelines for CIN and FN. Respondents were more likely to use clinical practice guidelines when they were expected to by physician and nurse colleagues, they perceived fewer barriers, or they held advanced oncology certification.
CONCLUSIONS: This study was the first to assess oncology nurses' reported use of NCCN clinical practice guidelines for CIN and FN. It also demonstrated the feasibility of partnering with ONS for Web-based survey research. IMPLICATIONS FOR NURSING: The findings give insight into work-place barriers to evidence-based practice in various settings. Expanding dissemination and implementation of clinical practice guideline recommendations will support the development of oncology nursing standards for risk assessment, management, and patient and family education in CIN and FN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059588     DOI: 10.1188/10.ONF.765-773

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  Iranian Nurses' Knowledge of Neutropenia and Their Practice for Infection Prevention in Patients with Cancer.

Authors:  Hamed Naghdi; Mansooreh Azizzadeh Forouzi; Mahlagha Dehghan
Journal:  J Cancer Educ       Date:  2021-06       Impact factor: 2.037

2.  Communicating safe outpatient management of fever and neutropenia.

Authors:  Christopher R Flowers; Clare Karten
Journal:  J Oncol Pract       Date:  2013-01-15       Impact factor: 3.840

3.  A cohort study on protocol-based nurse-led out-patient management of post-chemotherapy low-risk febrile neutropenia.

Authors:  Fiona Lim Mei Ying; Maria Choy Yin Ping; Macy Tong; Elaine Yim Pik Yan; Tracy Lui Siu Yee; Lam Yuk Ting; Anita Lo Wing Sim; Lui Cheuk Yu; Bosco Lam Hoi Shiu; Ashley Cheng Chi Kin
Journal:  Support Care Cancer       Date:  2018-03-20       Impact factor: 3.603

4.  Comparison between cancer specialists and general physicians regarding the education of nurse practitioners in Japan: a postal survey of the Japanese Society of Clinical Oncology.

Authors:  Yasushi Ishida; Masahiko Hatao; Osamu Fukushima; Michiko Mori; Fumiko Isozaki; Asako Okuyama
Journal:  Int J Clin Oncol       Date:  2012-08-11       Impact factor: 3.402

5.  Preconditions for successful guideline implementation: perceptions of oncology nurses.

Authors:  Kaori Yagasaki; Hiroko Komatsu
Journal:  BMC Nurs       Date:  2011-11-08

Review 6.  Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers.

Authors:  Wei Jin; Xiang Fei; Xia Wang; Yan Song; Fangjie Chen
Journal:  Mediators Inflamm       Date:  2020-05-04       Impact factor: 4.711

Review 7.  Subcutaneous Administration of Bortezomib: A Pilot Survey of Oncology Nurses.

Authors:  Jasmine R Martin; Nancy L Beegle; Yanyan Zhu; Ellen M Hanisch
Journal:  J Adv Pract Oncol       Date:  2015-07-01

Review 8.  miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.

Authors:  Noemi Arrighetti; Giovanni Luca Beretta
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.